ZNF263 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.40029999995406E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.00869998201858E-09 |
Normal-vs-Stage2 |
3.416400E-02 |
Normal-vs-Stage3 |
1.744160E-02 |
Normal-vs-Stage4 |
7.764200E-02 |
Stage1-vs-Stage2 |
6.902100E-02 |
Stage1-vs-Stage3 |
4.361600E-03 |
Stage1-vs-Stage4 |
5.600900E-04 |
Stage2-vs-Stage3 |
7.764000E-01 |
Stage2-vs-Stage4 |
4.640200E-01 |
Stage3-vs-Stage4 |
6.038400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.9123999999966E-05 |
Normal-vs-AfricanAmerican |
1.48699999980018E-07 |
Normal-vs-Asian |
9.375500E-03 |
Caucasian-vs-AfricanAmerican |
5.195100E-04 |
Caucasian-vs-Asian |
4.275000E-01 |
AfricanAmerican-vs-Asian |
5.717600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
8.242800E-04 |
Normal-vs-Female |
2.14259998632116E-09 |
Male-vs-Female |
2.446600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.737800E-01 |
Normal-vs-Age(41-60Yrs) |
3.22679999997799E-06 |
Normal-vs-Age(61-80Yrs) |
1.73411999999651E-05 |
Normal-vs-Age(81-100Yrs) |
2.194800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.883570E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.443400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.735600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.656000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.148400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.683600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.24050000774412E-10 |
Normal-vs-Grade 2 |
1.56650004079495E-09 |
Normal-vs-Grade 3 |
4.098700E-03 |
Normal-vs-Grade 4 |
6.795800E-01 |
Grade 1-vs-Grade 2 |
6.135600E-03 |
Grade 1-vs-Grade 3 |
3.97269999996563E-06 |
Grade 1-vs-Grade 4 |
1.46309999671246E-08 |
Grade 2-vs-Grade 3 |
1.625350E-04 |
Grade 2-vs-Grade 4 |
1.35409999990621E-07 |
Grade 3-vs-Grade 4 |
3.863800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.63350016741038E-10 |
Normal-vs-ccB subtype |
1.149560E-01 |
ccA subtype-vs-ccB subtype |
3.42089999993966E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.1372000000004E-05 |
Normal-vs-N1 |
9.801000E-01 |
N0-vs-N1 |
1.068600E-01 |
|
|